Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G for Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRBD).
- Disclosed ownership: 22%.
- Date of event: 06 Oct 2025.
Ikarian Capital, LLC - 06 Oct 2025 SCHEDULE 13G Report for Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRBD)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- SPRBD
- Shares outstanding
- 561,833 shares
- Disclosed Ownership
- 121,356 shares
- Ownership
- 22%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Oct 2025, 11:04:21 UTC
- Date of event
- 06 Oct 2025
- Next filing
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 22% ownership in Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRBD) on 06 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Oct 2025, 11:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 22% | 121,356 | 0 | 121,356 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 22% | 121,356 | 0 | 121,356 | /s/ Neil Shahrestani | Neil Shahrestani |